Hepatitis C hos børn

Vibeke Brix Christensen; Sannie Brit Nordly; Bjørn Fischler; Mette Skalshøi Kjær; Marianne Hørby Jørgensen

Hepatitis C hos børn

Translated title of the contribution: Hepatitis C infection in children.

Vibeke Brix Christensen, Sannie Brit Nordly, Bjørn Fischler, Mette Skalshøi Kjær, Marianne Hørby Jørgensen

Abstract

Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

Translated title of the contribution	Hepatitis C infection in children.
Original language	Danish
Article number	V02130136
Journal	Ugeskrift for Laeger
Volume	176
Issue number	8
Pages (from-to)	722-725
Number of pages	4
ISSN	0041-5782
Publication status	Published - 14 Apr 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c16a69534d624cecab550fcbb4a46a85,

title = "Hepatitis C hos b{\o}rn",

abstract = "Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.",

author = "Christensen, {Vibeke Brix} and Nordly, {Sannie Brit} and Bj{\o}rn Fischler and Kj{\ae}r, {Mette Skalsh{\o}i} and J{\o}rgensen, {Marianne H{\o}rby}",

year = "2014",

month = apr,

day = "14",

language = "Dansk",

volume = "176",

pages = "722--725",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Hepatitis C hos børn

AU - Christensen, Vibeke Brix

AU - Nordly, Sannie Brit

AU - Fischler, Bjørn

AU - Kjær, Mette Skalshøi

AU - Jørgensen, Marianne Hørby

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

AB - Chronic hepatitis C (HCV) infection has a prevalence of 2-3% worldwide. The vertical transmission rate is approximately 5%. There is no evidence to recommend abstinence from breastfeeding or elective C-section to prevent transmission. In children, the natural history of HCV infection is typically benign, but liver cirrhosis and hepatocellulary carcinoma are later complications. Children with HCV infection may benefit from early treatment with pegylated interferon and ribavirin with duration depending on genotype. Overall, response to antiviral treatment of HCV infected children is comparable to results in adults.

M3 - Tidsskriftartikel

C2 - 25096460

SN - 0041-5782

VL - 176

SP - 722

EP - 725

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 8

M1 - V02130136

ER -

Hepatitis C hos børn

Abstract

UN SDGs

Fingerprint

Cite this